Bio-Rad Laboratories, Inc.
US ˙ NYSE ˙ US0905722072

SecurityBIO / Bio-Rad Laboratories, Inc.
InstitutionEthic Inc.
Latest Disclosed Ownership1,339 shares
Latest Disclosed Value $ 373,246
Ethic Inc. reports 30.22% decrease in ownership of BIO / Bio-Rad Laboratories, Inc.

On April 27, 2026 - Ethic Inc. filed a 13F-HR form disclosing ownership of 1,339 shares of Bio-Rad Laboratories, Inc. (US:BIO) valued at $373,246 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 1,919 shares of Bio-Rad Laboratories, Inc.. This represents a change in shares of -30.22% during the quarter. The current value of the position is $408,167 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F BIO RAD LABORATORIES INC CL A CL A 090572207 1,339 -580 -30.22 373 -35.80 0.0058
2026-02-03 2025-12-31 13F BIO RAD LABORATORIES INC CL A CL A 090572207 1,919 1,193 164.33 581 186.21 0.0089
2025-10-17 2025-09-30 13F BIO RAD LABORATORIES INC CL A COM 090572207 726 -1,843 -71.74 204 -67.57 0.0033
2025-07-30 2025-06-30 13F BIO RAD LABORATORIES INC CL A COM 090572207 2,569 -1,096 -29.90 627 -28.78 0.0112
2025-05-13 2025-03-31 13F BIO RAD LABORATORIES INC CL A COM 090572207 3,665 2,067 129.35 880 67.75 0.0178
2025-02-14 2024-12-31 13F BIO RAD LABORATORIES INC CL A COM 090572207 1,598 522 48.51 525 40.86 0.0106
2024-11-13 2024-09-30 13F BIO RAD LABS CL A 090572207 1,076 132 13.98 372 44.75 0.0094
2024-08-13 2024-06-30 13F BIO RAD LABS CL A 090572207 944 -132 -12.27 258 -30.91 0.0060
2024-05-13 2024-03-31 13F BIO RAD LABS CL A 090572207 1,076 -372 -25.69 372 -20.34 0.0094
2024-02-14 2023-12-31 13F BIO RAD LABS CL A 090572207 1,448 403 38.56 468 24.87 0.0138
2023-11-14 2023-09-30 13F BIO RAD LABS CL A 090572207 1,045 -419 -28.62 375 -32.61 0.0131
2023-08-14 2023-06-30 13F BIO RAD LABS CL A 090572207 1,464 -349 -19.25 555 -36.06 0.0206
2023-05-12 2023-03-31 13F BIO RAD LABS CL A 090572207 1,813 -276 -13.21 868 -1.14 0.0352
2023-02-14 2022-12-31 13F BIO RAD LABS CL A 090572207 2,089 146 7.51 878 8.26 0.0475
2022-11-14 2022-09-30 13F BIO RAD LABS CL A 090572207 1,943 766 65.08 811 39.11 0.0550
2022-08-10 2022-06-30 13F BIO RAD LABS CL A 090572207 1,177 1,177 583 0.0406
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.